Lower plasma apolipoprotein A1 levels are found in Parkinson's disease and associate with apolipoprotein A1 genotype (Q27333275)

25 June 2017

Lower plasma apolipoprotein A1 levels are found in Parkinson's disease and associate with apolipoprotein A1 genotype (English)

1 reference

25 June 2017

1 reference

15

1 reference

25 June 2017

14

John Q Trojanowski

1 reference

25 June 2017

13

Daniel Weintraub

1 reference

25 June 2017

8

John Roberts

1 reference

25 June 2017

7

James Leverenz

1 reference

25 June 2017

9

Ali Samii

1 reference

25 June 2017

6

Pinky Agarwal

1 reference

25 June 2017

Vivianna M Van Deerlin

5

object named as

Vivianna M Van Deerlin

1 reference

25 June 2017

11

Howard Hurtig

1 reference

25 June 2017

Christine R Swanson

1

1 reference

25 June 2017

Katherine Li

2

1 reference

25 June 2017

Travis L Unger

3

1 reference

25 June 2017

Michael D Gallagher

4

1 reference

25 June 2017

Rachel Goldmann Gross

10

1 reference

25 June 2017

Jacqueline Rick

12

1 reference

25 June 2017

Alice S Chen-Plotkin

16

1 reference

25 June 2017

language of work or name

English

0 references

publication date

16 September 2014

1 reference

25 June 2017

1 reference

25 June 2017

30

1 reference

25 June 2017

805-812

1 reference

25 June 2017

6

1 reference

An integrated map of genetic variation from 1,092 human genomes

25 June 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4362847

An integrated encyclopedia of DNA elements in the human genome

21 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4362847

Does vigorous exercise have a neuroprotective effect in Parkinson disease?

21 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4362847

Genome-wide association study reveals genetic risk underlying Parkinson's disease

21 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4362847

APOA1 polymorphism influences risk for early-onset nonfamiliar AD

21 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4362847

Ageing and Parkinson's disease: substantia nigra regional selectivity

21 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4362847

A platform for discovery: The University of Pennsylvania Integrated Neurodegenerative Disease Biobank

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4362847

Plasma apolipoprotein A1 as a biomarker for Parkinson disease

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4362847

Cerebrospinal fluid biomarkers of neuropathologically diagnosed Parkinson's disease subjects

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4362847

Prospective study of statin use and risk of Parkinson disease

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4362847

Apolipoprotein A1/C3/A5 haplotypes and serum lipid levels

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4362847

Plasma epidermal growth factor levels predict cognitive decline in Parkinson disease

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4362847

α-Synuclein and tau concentrations in cerebrospinal fluid of patients presenting with parkinsonism: a cohort study

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4362847

Overexpression of human apolipoprotein A-I preserves cognitive function and attenuates neuroinflammation and cerebral amyloid angiopathy in a mouse model of Alzheimer disease.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4362847

Apolipoprotein A-I deficiency increases cerebral amyloid angiopathy and cognitive deficits in APP/PS1DeltaE9 mice

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4362847

Significance and confounders of peripheral DJ-1 and alpha-synuclein in Parkinson's disease.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4362847

DJ-1 and alpha-synuclein in human cerebrospinal fluid as biomarkers of Parkinson's disease

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4362847

Common variants at 7p21 are associated with frontotemporal lobar degeneration with TDP-43 inclusions

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4362847

Geographic and ethnic variation in Parkinson disease: a population-based study of US Medicare beneficiaries.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4362847

Tetranectin and apolipoprotein A-I in cerebrospinal fluid as potential biomarkers for Parkinson's disease

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4362847

An APOA1 promoter polymorphism is associated with cognitive performance in patients with multiple sclerosis

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4362847

Serum urate as a predictor of clinical and radiographic progression in Parkinson disease

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4362847

Projected number of people with Parkinson disease in the most populous nations, 2005 through 2030.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4362847

The role of drug transporters at the blood-brain barrier

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4362847

Parkinson's disease risks associated with cigarette smoking, alcohol consumption, and caffeine intake

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4362847

Quantitation of plasma apolipoproteins in the primary and secondary prevention of coronary artery disease

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4362847

A polymorphism (G-->A transition) in the -78 position of the apolipoprotein A-I promoter increases transcription efficiency

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4362847

The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4362847

Polymorphism in the human apolipoprotein A-I gene promoter region. Association of the minor allele with decreased production rate in vivo and promoter activity in vitro

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4362847

The intestine as a source of apolipoprotein A1

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4362847

Apolipoprotein B and A-I values in 147576 Swedish males and females, standardized according to the World Health Organization-International Federation of Clinical Chemistry First International Reference Materials.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4362847

Polymorphism in the promoter region of the apolipoprotein AI gene associated with differences in apolipoprotein AI levels: the European Atherosclerosis Research Study

2 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4362847

Discontinuation of statin therapy associates with Parkinson disease: a population-based study.

2 June 2018

1 reference

Crossref

https://api.crossref.org/works/10.1002%2FMDS.26022

Gene-diet interactions on plasma lipid levels in the Inuit population

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1002%2FMDS.26022

Apolipoprotein A1 genotype affects the change in high density lipoprotein cholesterol subfractions with exercise training

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1002%2FMDS.26022

New genetic variants in the apoA-I and apoC-III genes and familial combined hyperlipidemia

21 January 2018

1 reference

12 December 2020

Polyunsaturated fatty acids modulate the effects of the APOA1 G-A polymorphism on HDL-cholesterol concentrations in a sex-specific manner: the Framingham Study

1 reference

12 December 2020

G to A substitution in the promoter region of the apolipoprotein AI gene is associated with elevated serum apolipoprotein AI and high density lipoprotein cholesterol concentrations

1 reference

12 December 2020

Human apolipoprotein A-I gene promoter polymorphism: association with hyperalphalipoproteinemia

1 reference

12 December 2020

Interaction between a polymorphism of the apo A-I promoter region and smoking determines plasma levels of HDL and apo A-I

1 reference

12 December 2020

Haplotype analysis of two APOA1/MspI polymorphisms in relation to plasma levels of apo A-I and HDL-cholesterol

1 reference

12 December 2020

Mild association between the A/G polymorphism in the promoter of the apolipoprotein A-I gene and apolipoprotein A-I levels: A meta-analysis

1 reference

12 December 2020

Genetic polymorphisms in the APOA1 gene and their relationship with serum HDL cholesterol levels

1 reference

12 December 2020

Identifiers

DOI

10.1002/MDS.26022

1 reference

25 June 2017

0 references

1 reference